The Mastologist and the Patient with Mammary Siliconomas

  • Edgardo T. BernardelloEmail author


Many of the pathologies that confront mastologists involve a resolution that warrants little to no discussion. The same is not true when patients consult after having allowed themselves to undergo liquid silicone injections into their breasts. As Prats Esteve pointed out a decade ago (Prats Esteve, Rev Senología y Patol Mam 16(2):43–44, 2003), the same three fundamental questions must be asked: How could this have happened? What are the risks to these women? What is the recommended action?

Although the US Federal Drug Administration (FDA) never authorized the use of liquid silicones in mastology (Food and Drug Administration. Current and Useful Information on Collagen and Liquid Silicone Injections. FDA Backgrounder, BG91-2.0, 1991; Physicians to stop Injecting Silicone for Cosmetic Treatment of Wrinkles. Food and Drug Administration. Press Release 11/07/1992; 92–95), they still are used in practice. The unfortunate reality is that the practice of silicone breast injections can lead to pathology that, albeit uncommonly, can endanger a patient’s life.

Imaging is required when there is silicone in the breast, whether by direct injection or leakage from a breast prosthesis. Moreover, silicone can migrate beyond the breast, into the axilla, chest wall, and beyond, into other anatomical areas like the mediastinum. The surgeon must try to remove all the silicone – which may be unlikely if it has spread. Subsequent identification of silicone remnants does not invalidate or belittle what has been achieved, since “curing” the pathology faced during surgery must be the prevailing goal; and silicone remnants may remain asymptomatic indefinitely.


Axillary adenopathies Axillary images Mammography Mastologist  Sentinel ganglion Breast cancer Subcutaneous mastectomy 


  1. 1.
    Prats Esteve M. Silicona y senología... ¡Y parecía que estaba resuelto! Editorial. Rev Senología y Patol Mam. 2003;16(2):43–4.Google Scholar
  2. 2.
    Food and Drug Administration. Current and useful information on collagen and liquid silicone injections. FDA Backgrounder. 1991. BG91-2.0.Google Scholar
  3. 3.
    Physicians to stop Injecting Silicone for Cosmetic Treatment of Wrinkles. Food and Drug Administration. Press Release 11/07/1992; 92–5.Google Scholar
  4. 4.
    Bryan Ph R, Daniels CE, Shah SS, et al. Silicone breast implant-induced lymphadenopathy: 18 cases. Respiratory Medicine CME. 2011;4:126–30.CrossRefGoogle Scholar
  5. 5.
    Wang J, Shih TT, Li YW, et al. Magnetic resonance imaging characteristics of paraffinomas and siliconomas after mammoplasty. J Formos Med Assoc. 2002;101(2):117–23.PubMedGoogle Scholar
  6. 6.
    Scaranelo AM, de Fátima Ribeiro Maia M. Sonographic and mammographic findings of breast liquid silicone injection. J Clin Ultrasound. 2006;34(6):273–7.CrossRefGoogle Scholar
  7. 7.
    Youk JH, Son EJ, Kim EK, et al. Diagnosis of breast cancer at dynamic MRI in patients with breast augmentation by paraffin or silicone injection. J Plast Reconstr Aesthet Surg. 2011;64(6):731–7.CrossRefGoogle Scholar
  8. 8.
    Cheung YC, Su MY, Ng SH, et al. Lumpy silicone-injected breasts: enhanced MRI and microscopic correlation. Clin Imaging. 2002;26(6):397–404.CrossRefGoogle Scholar
  9. 9.
    Peng HL, Wu CC, Choi WM, et al. Breast cancer detection using magnetic resonance imaging in breasts injected with liquid silicone. Plast Reconstr Surg. 1999;104(7):2116–20.CrossRefGoogle Scholar
  10. 10.
    Grubstein A, Cohen M, Steinmetz A, et al. Siliconomas mimicking cancer. Clin Imaging. 2011;35(3):228–31.CrossRefGoogle Scholar
  11. 11.
    Chen CJ, Lee BF, Yao WJ, et al. A false positive F-FDG PET/CT scan caused by breast silicone injection. Korean J Radiol. 2009;10(2):194–6.CrossRefGoogle Scholar
  12. 12.
    Patel CN, Macpherson RE, Bradley KM. False-positive axillary lymphadenopathy due to silicone granuloma on FDG PET/CT. Eur J Nucl Med Mol Imaging. 2010;37(12):2405.CrossRefGoogle Scholar
  13. 13.
    Liu S, Lim AA. Evaluation and treatment of surgical management of silicone mastitis. J Cutan Aesthet Surg. 2012;5(3):193–6.CrossRefGoogle Scholar
  14. 14.
    Echo A, Otake LR, Mehrara BJ, et al. Surgical management of silicone mastitis: case series and review of the literature. Aesthet Plast Surg. 2013;37(4):738–45.CrossRefGoogle Scholar
  15. 15.
    Chiu WK, Lee TP, Chen SY, et al. Bilateral breast reconstruction with a pedicled transverse rectus abdominis myocutaneous flap after subcutaneous mastectomy for symptomatic injected breasts. J Plast Surg Hand Surg. 2012;46(3–4):242–7.CrossRefGoogle Scholar
  16. 16.
    Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for while females who are being examined annually. J Nat Cancer Inst. 1989;81(24):1879–86.CrossRefGoogle Scholar
  17. 17.
    Francken AB, Schouten PC, Bleiker EM, et al. Breast cancer in women at high risk: The role of rapid genetic testing for BRCA1 and -2 mutations and the consequences for treatment strategies. Breast. 2013;22(5):561–8.CrossRefGoogle Scholar
  18. 18.
    Schenone GE. Siliconomas Mamarios por Inyección: Clínica, Diagnóstico y Tratamiento. Buenos Aires: Ed. Journal; 2017. p. 89–94.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Faculty of MedicineUniversity of Buenos Aires (UBA)Buenos AiresArgentina
  2. 2.Argentine School of MastologyBuenos AiresArgentina

Personalised recommendations